First Tracks Biotherapeutics TRAX
NASDAQ TRAX
$46.56 -0.54 (-1.15%)
At close: Nov 16, 2026 · 4:00 PM EST

First Tracks Biotherapeutics (TRAX) Current Leases (2024 - 2026)

Updated

First Tracks Biotherapeutics (TRAX) recorded Current Leases of $2.42 million in Q3 2026, down 0.7% from the prior quarter.

Analysis

First Tracks Biotherapeutics (TRAX) Current Leases (2024 - 2026) Analysis & Trends

At the end of FY2025, First Tracks Biotherapeutics reported Current Leases of $2.08 million, up 8.1% from FY2024.

  • Across earlier years, Current Leases came in at $1.93 million in FY2024.
  • Quarterly Current Leases has ranged from $1.93 million in Q4 2024 to $2.44 million in Q2 2026 over the past five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn -
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn -
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn -
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn -
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn -
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn -
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn -
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn -
10 First Tracks Biotherapeutics 1.66 Bn 740.14 Mn - 2.42 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 2.42 Mn
Jun 30, 2026 2.44 Mn
Dec 31, 2025 2.08 Mn
Dec 31, 2024 1.93 Mn
API Access

First Tracks Biotherapeutics Current Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-leases&ticker=TRAX&period=max&api_key=YOUR_API_KEY